(Q48858316)

English

Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.

scientific article published in April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Norio Yasui-Furukori

1

object named as

Norio Yasui-Furukori

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

author name string

Shoko Tsuchimine

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Taku Nakagami

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Akira Fujii

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Yasushi Sato

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Tetsu Tomita

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Kaori Yoshizawa

7

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Yoshimasa Inoue

8

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Sunao Kaneko

9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

26

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

194-200

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Paroxetine increases brain-derived neurotrophic factor in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Antidepressants and neuroplasticity

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Role of neurotrophic factors in the etiology and treatment of mood disorders

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Postsynaptic inositol 1,4,5-trisphosphate signaling maintains presynaptic function of parallel fiber-Purkinje cell synapses via BDNF

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Paroxetine serum concentrations in depressed patients and response to treatment

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

The impact of age, weight and gender on BDNF levels in human platelets and plasma

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Neurobiology of depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Propagation of major depressive disorder: relationship between first episode symptoms and recurrence

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

beta-Estradiol induces synaptogenesis in the hippocampus by enhancing brain-derived neurotrophic factor release from dentate gyrus granule cells

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Recent progress in studies of neurotrophic factors and their clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Plasma BDNF and tPA are associated with late-onset geriatric depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Role for brain-derived neurotrophic factor in learning and memory

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference?

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

21 January 2018

BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA)

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters

1 reference

https://api.crossref.org/works/10.1002%2FHUP.1192

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.1192

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21638327

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48858316&oldid=1465193989"